Signadori Bio
Pre-clinicalSignadori Bio is a preclinical stage biopharmaceutical company developing an innovative cell therapy approach to treat cancer. The proprietary platform developed by Signadori comes from Institut Gustave Roussy a world leading oncology center
Founded
2021
Focus
Cell & Gene Therapy
About
Signadori Bio is a preclinical stage biopharmaceutical company developing an innovative cell therapy approach to treat cancer. The proprietary platform developed by Signadori comes from Institut Gustave Roussy a world leading oncology center
Company Info
TypePrivate
Founded2021
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile